ANSTO Nuclear Medicine Facility

Lucas Heights, New South Wales
  • Client Australian Nuclear Science and Technology Organisation
  • Market Health and Science
  • Division Construction
  • Value $84 million
  • Status Completed

The newly completed multi-level 4,250 square metre facility will significantly increase ANSTO’s capacity to produce the radioisotope molybdenum-99 – an active pharmaceutical ingredient used in more than 45 million nuclear medicine diagnostic procedures each year, worldwide.

The facility is classified as a nuclear installation and was designed and built to meet the requirements of the Australian Radiation Protection and Nuclear Safety Agency and Australian Non-proliferation and Safeguards Office.

ANSTO Nuclear Medicine Facility

What are you looking for?

Type in your search query and press enter.